ArticleJournal of the American Geriatrics Society2025
A Prospective Study on Potentially Inappropriate Drug Use and All-Cause Mortality in Community-Dwelling Older Adults.
Article in Journal of the American Geriatrics Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A multidisciplinary, AI-supported quality improvement intervention to manage polypharmacy in aging people with HIV.HIV medicine · 2026Article
- Medication Therapy Management Guided by TIME Criteria in Nursing Home Residents: A Before-After Observational Study.Journal of clinical medicine · 2026Article
- A Prospective Study on Potentially Inappropriate Drug Use and All-Cause Mortality in Community-Dwelling Older Adults.Journal of the American Geriatrics Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPotentially inappropriate prescribing (PIP), encompassing potentially inappropriate medications (PIMs) and prescribing omissions (PPOs), is prevalent among older adults and consistently associated with adverse health outcomes. However, evidence on its impact on mortality remains limited. We examined the associations of PIMs and PPOs with long-term mortality in a cohort of community-dwelling older adults.
methodsOne thousand two hundred and ten participants from the third follow-up (1999-2007) of a longitudinal prospective cohort study were followed for mortality until 03/2022. PIMs and PPOs were identified using the 2023 Beers and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) v3 criteria. Cox proportional hazards and Fine-Gray subdistribution hazard models assessed associations between PIP and all-cause and non-cancer mortality, respectively, adjusting for sociodemographic, lifestyle, and health-related factors.
resultsOverall, 81.2% of participants were exposed to > 1 problem: 52.6% and 45.0% to PIMs based on Beers and STOPP criteria, respectively, and 59.3% to PPOs. In multivariable analysis, exposure to ≥ 2 PIMs was associated with increased all-cause mortality for Beers (HR = 1.31, 95% CI: 1.04-1.69) and STOPP (HR = 1.25, 95% CI: 1.00-1.55) criteria. An interaction between PIMs (Beers criteria) and self-rated health (SRH) indicated stronger associations for those with "excellent/good" baseline SRH, compared to those with "poor/very poor" SRH (p-for-interaction = 0.030). Use of ≥ 2 PIMs was also associated with a 1.4-fold increased non-cancer mortality risk for both tools. Exposure to ≥ 2 PPOs was associated with a 1.8-fold increase in all-cause mortality risk (HR = 1.84, 95% CI: 1.24-2.72), while associations were stronger in men (p-for-interaction = 0.012). Exposure to 1 or ≥ 2 PPOs was also associated with 1.3 and 2.0-fold increased non-cancer mortality risk, respectively.
conclusionsPIP is prevalent and is associated with increased long-term mortality among community-dwelling older adults. Addressing PIMs in healthier older individuals and reducing PPOs in clinical practice is critical. Sex-specific pharmaceutical guidelines are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.